gfp, I sold all my PRVB around $12.50. I had 100,000 shares with an average cost basis around $16 and change, so I took a big loss. I just thought there were better places for my money and I could use the tax loss.
Small and micro-cap biotechs are definitely out of favor now and I don't know when that will turn around, if ever.
I'm still holding ONCT and KZIA. My cancer docs love FSTX (needs cash) and MYOV (gotten very cheap). We all love MGTA. Cancer docs also like CRIS a lot. One doc likes MEIP and another one likes TRIL. I own a medium sized position in TRIL. I sold all of my MEIP a long time ago, but may consider re-entering.
I personally like CRVS. Cancer docs are lukewarm on it.
Besides FSTX, the big, big sleeper is BPTH. With a market cap around $45 million, it seems way undervalued. Of course, I said that when it was $7.
I think you should look at MGTA, FSTX and BPTH. All are very cheap and all have explosive upside.
Bladerunner
